A cell cycle–related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma
Authors:
Open Access
- 27 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1110987
Abstract
The cell cycle plays a vital role in tumorigenesis and progression. Long non-coding RNAs (lncRNAs) are key regulators of cell cycle processes. Therefore, understanding cell cycle–related lncRNAs (CCR-lncRNAs) is crucial for determining the prognosis of papillary thyroid carcinoma (PTC). RNA-seq and clinical data of PTC were acquired from The Cancer Genome Atlas, and CCR-lncRNAs were selected based on Pearson’s correlation coefficients. According to univariate Cox regression, least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analyses, a five-CCR-lncRNA signature (FOXD2-AS1, LOC100507156, BSG-AS1, EGOT, and TMEM105) was established to predict the progression-free interval (PFI) in PTC. Kaplan–Meier survival, time-dependent receiver operating characteristic curve, and multivariate Cox regression analyses proved that the signature had a reliable prognostic capability. A nomogram consisting of the risk signature and clinical characteristics was constructed that effectively predicted the PFI in PTC. Functional enrichment analyses indicted that the signature was involved in cell cycle– and immune-related pathways. Furthermore, we also analyzed the correlation between the signature and immune cell infiltration. Finally, we verified the differential expression of CCR-lncRNAs in vitro using quantitative real-time polymerase chain reaction. Overall, the newly developed prognostic risk signature based on five CCR-lncRNAs may become a marker for predicting the PFI in PTC.Keywords
Funding Information
- National Natural Science Foundation of China (82073491, 81872560)
This publication has 47 references indexed in Scilit:
- Heterogeneity of Thyroid CancerPathobiology, 2018
- Long noncoding RNAs: emerging players in thyroid cancer pathogenesisEndocrine-Related Cancer, 2018
- Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancerSurgery, 2018
- LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric CancerPathology and Oncology Research, 2017
- Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinomaMolecular Medicine Reports, 2017
- Biologic and Clinical Perspectives on Thyroid CancerNew England Journal of Medicine, 2016
- New developments in the diagnosis and treatment of thyroid cancerCA: A Cancer Journal for Clinicians, 2013
- Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiterEndocrine, 2012
- Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinomaClinical Endocrinology, 2012
- Phenotypical Analysis of Lymphocytes with Suppressive and Regulatory Properties (Tregs) and NK Cells in the Papillary Carcinoma of ThyroidThe Journal of Clinical Endocrinology & Metabolism, 2012